Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec;78(3):395-405.
doi: 10.1007/s12020-022-03076-x. Epub 2022 May 23.

Endocrine disrupting chemicals: effects on pituitary, thyroid and adrenal glands

Affiliations
Review

Endocrine disrupting chemicals: effects on pituitary, thyroid and adrenal glands

Filippo Egalini et al. Endocrine. 2022 Dec.

Abstract

Background: In recent years, scientific research has increasingly focused on Endocrine Disrupting Chemicals (EDCs) and demonstrated their relevant role in the functional impairment of endocrine glands. This induced regulatory authorities to ban some of these compounds and to carefully investigate others in order to prevent EDCs-related conditions. As a result, we witnessed a growing awareness and interest on this topic.

Aims: This paper aims to summarize current evidence regarding the detrimental effects of EDCs on pivotal endocrine glands like pituitary, thyroid and adrenal ones. Particularly, we directed our attention on the known and the hypothesized mechanisms of endocrine dysfunction brought by EDCs. We also gave a glimpse on recent findings from pioneering studies that could in the future shed a light on the pathophysiology of well-known, but poorly understood, endocrine diseases like hormone-producing adenomas.

Conclusions: Although intriguing, studies on endocrine dysfunctions brought by EDCs are challenging, in particular when investigating long-term effects of EDCs on humans. However, undoubtedly, it represents a new intriguing field of science research.

Keywords: Adrenal gland; Endocrine disrupting chemicals; Endocrine disruptors; Pituitary gland; Thyroid gland.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS, Toppari J, Zoeller RT. EDC-2: the endocrine society’s second scientific statement on endocrine-disrupting chemicals. Endocr. Rev. 2015;36:E1–E150. doi: 10.1210/er.2015-1010. - DOI - PMC - PubMed
    1. Kabir ER, Rahman MS, Rahman I. A review on endocrine disruptors and their possible impacts on human health. Environ. Toxicol. Pharmacol. 2015;40:241–258. doi: 10.1016/j.etap.2015.06.009. - DOI - PubMed
    1. Balaguer P, Delfosse V, Grimaldi M, Bourguet W. Structural and functional evidences for the interactions between nuclear hormone receptors and endocrine disruptors at low doses. Comptes Rendus Biologies. 2017;340:414–420. doi: 10.1016/j.crvi.2017.08.002. - DOI - PubMed
    1. Heindel JJ, Newbold R, Schug TT. Endocrine disruptors and obesity. Nat. Rev. Endocrinol. 2015;11:653–661. doi: 10.1038/nrendo.2015.163. - DOI - PubMed
    1. Sargis RM. Metabolic disruption in context: Clinical avenues for synergistic perturbations in energy homeostasis by endocrine disrupting chemicals. Endocr. Disruptors. 2015;3:e1080788. doi: 10.1080/23273747.2015.1080788. - DOI - PMC - PubMed

Substances